Variant report
Variant | nsv526086 |
---|---|
Chromosome Location | chr11:71867167-71872777 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:8)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:8 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:71871545-71871605 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr11:71871429-71871762 | IMR90 | lung: | n/a | n/a |
3 | FOS | chr11:71871368-71871734 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr11:71871366-71871692 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr11:71871366-71871732 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr11:71871369-71871704 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | GATA1 | chr11:71867791-71868624 | PBDE | blood: | n/a | n/a |
8 | MYC | chr11:71871417-71871606 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000256518 | TF binding region |
ENSG00000110200 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs590586 | chr11:71867167-71867168 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs184810100 | chr11:71867237-71867238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573128689 | chr11:71867389-71867390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs555168405 | chr11:71867406-71867407 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs190373289 | chr11:71867412-71867413 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs147661075 | chr11:71867450-71867451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181055367 | chr11:71867480-71867481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184144038 | chr11:71867552-71867553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs573612578 | chr11:71867562-71867563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562630242 | chr11:71867571-71867572 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530001202 | chr11:71867613-71867614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541728122 | chr11:71867691-71867692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs373811623 | chr11:71867727-71867728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75313463 | chr11:71867841-71867842 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
15 | rs189861937 | chr11:71867881-71867882 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs200957441 | chr11:71867903-71867904 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs181146972 | chr11:71867905-71867906 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs535135704 | chr11:71867940-71867941 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs570212509 | chr11:71867974-71867975 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs185640332 | chr11:71867989-71867990 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs693273 | chr11:71867993-71867994 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
22 | rs550771683 | chr11:71868005-71868006 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs190746246 | chr11:71868014-71868015 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs148907882 | chr11:71868100-71868101 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs548567186 | chr11:71868220-71868221 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs76112079 | chr11:71868243-71868244 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs181589808 | chr11:71868252-71868253 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs559134534 | chr11:71868267-71868268 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs577424684 | chr11:71868271-71868272 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs11235456 | chr11:71868346-71868347 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs186555123 | chr11:71868392-71868393 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs148036436 | chr11:71868399-71868400 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs542139777 | chr11:71868434-71868435 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs141710502 | chr11:71868440-71868441 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs150139248 | chr11:71868491-71868492 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs561535796 | chr11:71868538-71868539 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs563701289 | chr11:71868548-71868549 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs115867829 | chr11:71868559-71868560 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs549438284 | chr11:71868577-71868578 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs563114310 | chr11:71868582-71868583 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs530209940 | chr11:71868600-71868601 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs548909837 | chr11:71868603-71868604 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs11400542 | chr11:71868618-71868619 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs397750215 | chr11:71868620-71868621 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs398088099 | chr11:71868626-71868627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397755410 | chr11:71868627-71868628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567043381 | chr11:71868675-71868676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs670507 | chr11:71868759-71868760 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs117589756 | chr11:71868897-71868898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs561208455 | chr11:71868909-71868910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71863600-71871000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr11:71864000-71867400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
3 | chr11:71864200-71867400 | Weak transcription | NHEK | skin |
4 | chr11:71866200-71867800 | Weak transcription | K562 | blood |
5 | chr11:71867400-71868600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr11:71867400-71868600 | Enhancers | NHEK | skin |
7 | chr11:71867800-71868400 | Enhancers | K562 | blood |
8 | chr11:71868400-71874000 | Weak transcription | K562 | blood |
9 | chr11:71868600-71871200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr11:71868600-71873200 | Weak transcription | NHEK | skin |
11 | chr11:71870000-71870200 | Bivalent Enhancer | Stomach Smooth Muscle | stomach |
12 | chr11:71871000-71871600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr11:71871200-71871600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr11:71871200-71871800 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr11:71871400-71871800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr11:71871600-71871800 | Enhancers | NHLF | lung |
17 | chr11:71871600-71874000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr11:71871600-71874800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |